These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 32264722)

  • 1. A review of antibody-based therapeutics targeting G protein-coupled receptors: an update.
    Hutchings CJ
    Expert Opin Biol Ther; 2020 Aug; 20(8):925-935. PubMed ID: 32264722
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Engineering therapeutic antibodies targeting G-protein-coupled receptors.
    Jo M; Jung ST
    Exp Mol Med; 2016 Feb; 48(2):e207. PubMed ID: 26846450
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mini-review: antibody therapeutics targeting G protein-coupled receptors and ion channels.
    Hutchings CJ
    Antib Ther; 2020 Dec; 3(4):257-264. PubMed ID: 33912796
    [TBL] [Abstract][Full Text] [Related]  

  • 4. GPCR-targeting nanobodies: attractive research tools, diagnostics, and therapeutics.
    Mujić-Delić A; de Wit RH; Verkaar F; Smit MJ
    Trends Pharmacol Sci; 2014 May; 35(5):247-55. PubMed ID: 24690241
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery and design of G protein-coupled receptor targeting antibodies.
    Peterson SM; Hutchings CJ; Hu CF; Mathur M; Salameh JW; Axelrod F; Sato AK
    Expert Opin Drug Discov; 2023 Apr; 18(4):417-428. PubMed ID: 36992620
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential use of G protein-coupled receptor-blocking monoclonal antibodies as therapeutic agents for cancers.
    Herr DR
    Int Rev Cell Mol Biol; 2012; 297():45-81. PubMed ID: 22608557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antigen Design for Successful Isolation of Highly Challenging Therapeutic Anti-GPCR Antibodies.
    Ju MS; Jung ST
    Int J Mol Sci; 2020 Nov; 21(21):. PubMed ID: 33153215
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery of functional monoclonal antibodies targeting G-protein-coupled receptors and ion channels.
    Wilkinson TC
    Biochem Soc Trans; 2016 Jun; 44(3):831-7. PubMed ID: 27284048
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of therapeutic antibodies to G protein-coupled receptors and ion channels: Opportunities, challenges and their therapeutic potential in respiratory diseases.
    Douthwaite JA; Finch DK; Mustelin T; Wilkinson TC
    Pharmacol Ther; 2017 Jan; 169():113-123. PubMed ID: 27153991
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Established and In-trial GPCR Families in Clinical Trials: A Review for Target Selection.
    Saikia S; Bordoloi M; Sarmah R
    Curr Drug Targets; 2019; 20(5):522-539. PubMed ID: 30394207
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Opportunities for therapeutic antibodies directed at G-protein-coupled receptors.
    Hutchings CJ; Koglin M; Olson WC; Marshall FH
    Nat Rev Drug Discov; 2017 Sep; 16(9):787-810. PubMed ID: 28706220
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nanobodies: New avenues for imaging, stabilizing and modulating GPCRs.
    De Groof TWM; Bobkov V; Heukers R; Smit MJ
    Mol Cell Endocrinol; 2019 Mar; 484():15-24. PubMed ID: 30690070
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Generating therapeutic monoclonal antibodies to complex multi-spanning membrane targets: Overcoming the antigen challenge and enabling discovery strategies.
    Dodd R; Schofield DJ; Wilkinson T; Britton ZT
    Methods; 2020 Aug; 180():111-126. PubMed ID: 32422249
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Production of monoclonal antibodies against GPCR using cell-free synthesized GPCR antigen and biotinylated liposome-based interaction assay.
    Takeda H; Ogasawara T; Ozawa T; Muraguchi A; Jih PJ; Morishita R; Uchigashima M; Watanabe M; Fujimoto T; Iwasaki T; Endo Y; Sawasaki T
    Sci Rep; 2015 Jun; 5():11333. PubMed ID: 26061673
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic antibodies directed at G protein-coupled receptors.
    Hutchings CJ; Koglin M; Marshall FH
    MAbs; 2010; 2(6):594-606. PubMed ID: 20864805
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A monoclonal antibody for G protein-coupled receptor crystallography.
    Day PW; Rasmussen SG; Parnot C; Fung JJ; Masood A; Kobilka TS; Yao XJ; Choi HJ; Weis WI; Rohrer DK; Kobilka BK
    Nat Methods; 2007 Nov; 4(11):927-9. PubMed ID: 17952087
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Structural Life Science towards the Regulation of Selective GPCR Signaling].
    Kobayashi T
    Yakugaku Zasshi; 2016; 136(2):179-84. PubMed ID: 26831790
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of an Antigen-Antibody Co-Display System for Detecting Interaction of G-Protein-Coupled Receptors and Single-Chain Variable Fragments.
    Zhang Y; Wu BJ; Yu X; Luo P; Ye H; Yu Y; Han W; Li J
    Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33946798
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent Advances in Structure-Based Drug Design Targeting Class A G Protein-Coupled Receptors Utilizing Crystal Structures and Computational Simulations.
    Lee Y; Basith S; Choi S
    J Med Chem; 2018 Jan; 61(1):1-46. PubMed ID: 28657745
    [TBL] [Abstract][Full Text] [Related]  

  • 20. X-ray structure breakthroughs in the GPCR transmembrane region.
    Topiol S; Sabio M
    Biochem Pharmacol; 2009 Jul; 78(1):11-20. PubMed ID: 19447219
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.